Abstract

Adipocytes store excess energy in the form of triglycerides and signal the levels of stored energy to the brain. Here we show that adipocyte-specific deletion of Arntl (also known as Bmal1), a gene encoding a core molecular clock component, results in obesity in mice with a shift in the diurnal rhythm of food intake, a result that is not seen when the gene is disrupted in hepatocytes or pancreatic islets. Changes in the expression of hypothalamic neuropeptides that regulate appetite are consistent with feedback from the adipocyte to the central nervous system to time feeding behavior. Ablation of the adipocyte clock is associated with a reduced number of polyunsaturated fatty acids in adipocyte triglycerides. This difference between mutant and wild-type mice is reflected in the circulating concentrations of polyunsaturated fatty acids and nonesterified polyunsaturated fatty acids in hypothalamic neurons that regulate food intake. Thus, this study reveals a role for the adipocyte clock in the temporal organization of energy regulation, highlights timing as a modulator of the adipocyte-hypothalamic axis and shows the impact of timing of food intake on body weight.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

Accessions

Primary accessions

Gene Expression Omnibus

References

  1. 1.

    , & The meter of metabolism. Cell 134, 728–742 (2008).

  2. 2.

    & Coordination of circadian timing in mammals. Nature 418, 935–941 (2002).

  3. 3.

    et al. Disruption of the clock components CLOCK and BMAL1 leads to hypoinsulinaemia and diabetes. Nature 466, 627–631 (2010).

  4. 4.

    , & Physiological significance of a peripheral tissue circadian clock. Proc. Natl. Acad. Sci. USA 105, 15172–15177 (2008).

  5. 5.

    et al. Disrupted fat absorption attenuates obesity induced by a high-fat diet in Clock mutant mice. FEBS Lett. 580, 127–130 (2006).

  6. 6.

    et al. Obesity and metabolic syndrome in circadian Clock mutant mice. Science 308, 1043–1045 (2005).

  7. 7.

    et al. BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis. PLoS Biol. 2, e377 (2004).

  8. 8.

    , & Study of shift work and risk of coronary events. J. R. Soc. Promot. Health 127, 265–267 (2007).

  9. 9.

    , & Is there an association between shift work and having a metabolic syndrome? Results from a population based study of 27,485 people. Occup. Environ. Med. 58, 747–752 (2001).

  10. 10.

    , , & Effects of poor and short sleep on glucose metabolism and obesity risk. Nat. Rev. Endocrinol. 5, 253–261 (2009).

  11. 11.

    et al. Role of leptin in the neuroendocrine response to fasting. Nature 382, 250–252 (1996).

  12. 12.

    et al. Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus. Nature 411, 480–484 (2001).

  13. 13.

    & Hypothalamic agouti-related protein messenger ribonucleic acid is inhibited by leptin and stimulated by fasting. Endocrinology 140, 814–817 (1999).

  14. 14.

    et al. Hypothalamic sensing of circulating fatty acids is required for glucose homeostasis. Nat. Med. 11, 320–327 (2005).

  15. 15.

    et al. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J. Clin. Invest. 116, 1081–1091 (2006).

  16. 16.

    et al. Unsaturated fatty acids revert diet-induced hypothalamic inflammation in obesity. PLoS ONE 7, e30571 (2012).

  17. 17.

    et al. Mop3 is an essential component of the master circadian pacemaker in mammals. Cell 103, 1009–1017 (2000).

  18. 18.

    et al. Progressive arthropathy in mice with a targeted disruption of the Mop3/Bmal-1 locus. Genesis 41, 122–132 (2005).

  19. 19.

    , , , & Early aging and age-related pathologies in mice deficient in BMAL1, the core component of the circadian clock. Genes Dev. 20, 1868–1873 (2006).

  20. 20.

    et al. Genetic components of the circadian clock regulate thrombogenesis in vivo. Circulation 117, 2087–2095 (2008).

  21. 21.

    et al. Adipose-specific peroxisome proliferator-activated receptor γ knockout causes insulin resistance in fat and liver but not in muscle. Proc. Natl. Acad. Sci. USA 100, 15712–15717 (2003).

  22. 22.

    , , , & Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res. 8, 265–277 (1999).

  23. 23.

    , , & Rhythmic histone acetylation underlies transcription in the mammalian circadian clock. Nature 421, 177–182 (2003).

  24. 24.

    et al. System-level identification of transcriptional circuits underlying mammalian circadian clocks. Nat. Genet. 37, 187–192 (2005).

  25. 25.

    , , & Characterization of the core mammalian clock component, NPAS2, as a REV-ERBα/RORα target gene. J. Biol. Chem. 285, 35386–35392 (2010).

  26. 26.

    et al. A clock shock: mouse CLOCK is not required for circadian oscillator function. Neuron 50, 465–477 (2006).

  27. 27.

    et al. Circadian and CLOCK-controlled regulation of the mouse transcriptome and cell proliferation. Proc. Natl. Acad. Sci. USA 104, 3342–3347 (2007).

  28. 28.

    , , , & System-driven and oscillator-dependent circadian transcription in mice with a conditionally active liver clock. PLoS Biol. 5, e34 (2007).

  29. 29.

    et al. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 13, 249–259 (2011).

  30. 30.

    et al. Leptin levels in human and rodent: measurement of plasma leptin and ob RNA in obese and weight-reduced subjects. Nat. Med. 1, 1155–1161 (1995).

  31. 31.

    , , , & Two defects contribute to hypothalamic leptin resistance in mice with diet-induced obesity. J. Clin. Invest. 105, 1827–1832 (2000).

  32. 32.

    et al. Binge eating disorder and the night-eating syndrome. Int. J. Obes. Relat. Metab. Disord. 20, 1–6 (1996).

  33. 33.

    , , & The basic-helix-loop-helix-PAS orphan MOP3 forms transcriptionally active complexes with circadian and hypoxia factors. Proc. Natl. Acad. Sci. USA 95, 5474–5479 (1998).

  34. 34.

    et al. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687–698 (2010).

  35. 35.

    et al. Loss of TGH/Ces3 in mice decreases blood lipids, improves glucose tolerance, and increases energy expenditure. Cell Metab. 11, 183–193 (2010).

  36. 36.

    et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569–574 (2004).

  37. 37.

    et al. IL-6 and IL-10 anti-inflammatory activity links exercise to hypothalamic insulin and leptin sensitivity through IKKβ and ER stress inhibition. PLoS Biol. 8, e1000465 (2010).

  38. 38.

    , & Adrenal glucocorticoids have a key role in circadian resynchronization in a mouse model of jet lag. J. Clin. Invest. 120, 2600–2609 (2010).

  39. 39.

    et al. Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans. PLoS Biol. 9, e1000623 (2011).

  40. 40.

    , , , & Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring) 17, 2100–2102 (2009).

  41. 41.

    et al. Circadian feeding drive of metabolic activity in adipose tissue and not hyperphagia triggers overweight in mice: is there a role of the pentose-phosphate pathway? Endocrinology 153, 690–699 (2012).

  42. 42.

    et al. Time-restricted feeding without reducing caloric intake prevents metabolic diseases in mice fed a high-fat diet. Cell Metab. 15, 848–860 (2012).

  43. 43.

    et al. Involvement of hypothalamic histamine H1 receptor in the regulation of feeding rhythm and obesity. Diabetes 53, 2250–2260 (2004).

  44. 44.

    , , , & Food intake during the normal activity phase prevents obesity and circadian desynchrony in a rat model of night work. Endocrinology 151, 1019–1029 (2010).

  45. 45.

    et al. Light at night increases body mass by shifting the time of food intake. Proc. Natl. Acad. Sci. USA 107, 18664–18669 (2010).

  46. 46.

    , , & Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc. Natl. Acad. Sci. USA 106, 4453–4458 (2009).

  47. 47.

    , , , & Categorically distinct acute stressors elicit dissimilar transcriptional profiles in the paraventricular nucleus of the hypothalamus. J. Neurosci. 23, 5607–5616 (2003).

  48. 48.

    et al. Increased hepatic oxidative metabolism distinguishes the action of peroxisome proliferator-activated receptor δ from peroxisome proliferator-activated receptor γ in the ob/ob mouse. Genome Med. 1, 115 (2009).

  49. 49.

    et al. Summaries of Affymetrix GeneChip probe level data. Nucleic Acids Res. 31, e15 (2003).

  50. 50.

    , & A practical false discovery rate approach to identifying patterns of differential expression in microarray data. Bioinformatics 21, 2684–2690 (2005).

Download references

Acknowledgements

This work was supported by US National Institutes of Health (NIH) grant RO1 HL097800 and Medical Research Council grant UD99999906. We thank M. Lazar for help with the ChIP experiments (funded by NIH R01 DK45586). We thank R. Ahima and the Mouse Phenotyping, Physiology and Metabolism Core of the Penn Diabetes Research Center (P30 DK19525) for performing body composition and behavioral analysis; D. Baldwin's Microarray Core Facility for performing the microarray analysis; and R. Freer and M. Adam for technical assistance. G.A.F. is the McNeil Professor of Translational Medicine and Therapeutics.

Author information

Affiliations

  1. Perelman School of Medicine, Institute for Translational Medicine and Therapeutics, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

    • Georgios K Paschos
    • , Salam Ibrahim
    • , Wen-Liang Song
    • , Takeshige Kunieda
    • , Gregory Grant
    • , Teresa M Reyes
    • , John A Lawson
    •  & Garret A FitzGerald
  2. McArdle Laboratory, Department of Oncology, University of Wisconsin, School of Medicine and Public Health, Madison, Wisconsin, USA.

    • Christopher A Bradfield
  3. Department of Biology, Center for Obesity Reversal, Georgia State University, Atlanta, Georgia, USA.

    • Cheryl H Vaughan
  4. Medical Research Council Human Nutrition Research, Elsie Widdowson Laboratory, Cambridge, UK.

    • Michael Eiden
    • , Mojgan Masoodi
    •  & Julian L Griffin
  5. Perelman School of Medicine, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania, Philadelphia, Pennsylvania, USA.

    • Fenfen Wang

Authors

  1. Search for Georgios K Paschos in:

  2. Search for Salam Ibrahim in:

  3. Search for Wen-Liang Song in:

  4. Search for Takeshige Kunieda in:

  5. Search for Gregory Grant in:

  6. Search for Teresa M Reyes in:

  7. Search for Christopher A Bradfield in:

  8. Search for Cheryl H Vaughan in:

  9. Search for Michael Eiden in:

  10. Search for Mojgan Masoodi in:

  11. Search for Julian L Griffin in:

  12. Search for Fenfen Wang in:

  13. Search for John A Lawson in:

  14. Search for Garret A FitzGerald in:

Contributions

G.K.P., S.I., W.-L.S., T.K., C.H.V. and F.W. contributed to the acquisition, analysis and interpretation of the data. G.K.P. and G.A.F. initiated and designed the study. G.G. performed statistical analyses and analysis of the microarray data. T.M.R. performed indirect calorimetric analyses. C.A.B. provided the mice with the conditional Arntl allele. M.E., M.M., J.L.G. and J.A.L. performed the liquid chromatography mass spectrometry (LC-MS) analysis. G.K.P. and G.A.F. wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Garret A FitzGerald.

Supplementary information

PDF files

  1. 1.

    Supplementary Text and Figures

    Supplementary Figures 1–8 and Supplementary Methods

About this article

Publication history

Received

Accepted

Published

DOI

https://doi.org/10.1038/nm.2979

Further reading Further reading